These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1312221)

  • 1. Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies.
    Bergström T; Sjögren-Jansson E; Jeansson S; Lycke E
    Mol Cell Probes; 1992 Feb; 6(1):41-9. PubMed ID: 1312221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains.
    Bergström T; Lycke E
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():405-10. PubMed ID: 2155294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins.
    Bhattarakosol P; Yoosook C; Cross A
    Arch Virol; 1990; 115(1-2):89-100. PubMed ID: 1701081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis.
    Lakeman FD; Koga J; Whitley RJ
    J Infect Dis; 1987 Jun; 155(6):1172-8. PubMed ID: 3033092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
    J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene.
    Izumi KM; Stevens JG
    J Exp Med; 1990 Aug; 172(2):487-96. PubMed ID: 2165127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system.
    Bergström T; Alestig K; Svennerholm B; Horal P; Sköldenberg B; Vahlne A
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):751-7. PubMed ID: 2175706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
    Glorioso J; Schröder CH; Kumel G; Szczesiul M; Levine M
    J Virol; 1984 Jun; 50(3):805-12. PubMed ID: 6328010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
    J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B.
    Goodman JL; Engel JP
    J Virol; 1991 Apr; 65(4):1770-8. PubMed ID: 1848305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L
    Dev Biol Stand; 1982; 52():115-31. PubMed ID: 6299824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
    Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC
    Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
    Pereira L; Dondero D; Norrild B; Roizman B
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5202-6. PubMed ID: 6272294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies.
    Koga J; Chatterjee S; Whitley RJ
    Virology; 1986 Jun; 151(2):385-9. PubMed ID: 3010559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR; Kühn JE; Braun RW
    J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.